Cargando…
Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells
Melanoma is a highly lethal type of cancer that has had an increase in incidence in the last decades. Nevertheless, current therapies lack effectiveness and have highly disabling side effects, which calls for new therapeutic strategies. Norcantharidin (NCTD) is an acid derivative with potential anti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143330/ https://www.ncbi.nlm.nih.gov/pubmed/37111258 http://dx.doi.org/10.3390/ph16040501 |
_version_ | 1785033826036088832 |
---|---|
author | Martínez-Razo, Gabriel Pires, Patrícia C. Domínguez-López, María Lilia Veiga, Francisco Vega-López, Armando Paiva-Santos, Ana Cláudia |
author_facet | Martínez-Razo, Gabriel Pires, Patrícia C. Domínguez-López, María Lilia Veiga, Francisco Vega-López, Armando Paiva-Santos, Ana Cláudia |
author_sort | Martínez-Razo, Gabriel |
collection | PubMed |
description | Melanoma is a highly lethal type of cancer that has had an increase in incidence in the last decades. Nevertheless, current therapies lack effectiveness and have highly disabling side effects, which calls for new therapeutic strategies. Norcantharidin (NCTD) is an acid derivative with potential antitumor activity isolated from natural blister beetles. However, its solubility limitations restrict its use. To address this issue, we developed an oil-in-water nanoemulsion using commonly available cosmetic ingredients, which increased NCTD solubility 10-fold compared to water. The developed nanoemulsion showed a good droplet size and homogeneity, with adequate pH and viscosity for skin application. In vitro drug release studies showed a sustained release profile, ideal for prolonged therapeutic effects. Accelerated stability studies proved that the formulation was reasonably stable under stress conditions, with particle separation fingerprints, instability index, particle size, and sedimentation velocity analyses being conducted. To assess the therapeutic potential of the developed formulation, in vitro studies were conducted on melanoma B16F1 cells; results showed an IC50 of 1.026 +/− 0.370 mg/kg, and the cells’ metabolic activity decreased after exposure to the NCTD nanoemulsion. Hence, a new “easy-to-make” nanoformulation with therapeutic potential on melanoma cells was developed, as a possible adjuvant for future melanoma treatment. |
format | Online Article Text |
id | pubmed-10143330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101433302023-04-29 Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells Martínez-Razo, Gabriel Pires, Patrícia C. Domínguez-López, María Lilia Veiga, Francisco Vega-López, Armando Paiva-Santos, Ana Cláudia Pharmaceuticals (Basel) Article Melanoma is a highly lethal type of cancer that has had an increase in incidence in the last decades. Nevertheless, current therapies lack effectiveness and have highly disabling side effects, which calls for new therapeutic strategies. Norcantharidin (NCTD) is an acid derivative with potential antitumor activity isolated from natural blister beetles. However, its solubility limitations restrict its use. To address this issue, we developed an oil-in-water nanoemulsion using commonly available cosmetic ingredients, which increased NCTD solubility 10-fold compared to water. The developed nanoemulsion showed a good droplet size and homogeneity, with adequate pH and viscosity for skin application. In vitro drug release studies showed a sustained release profile, ideal for prolonged therapeutic effects. Accelerated stability studies proved that the formulation was reasonably stable under stress conditions, with particle separation fingerprints, instability index, particle size, and sedimentation velocity analyses being conducted. To assess the therapeutic potential of the developed formulation, in vitro studies were conducted on melanoma B16F1 cells; results showed an IC50 of 1.026 +/− 0.370 mg/kg, and the cells’ metabolic activity decreased after exposure to the NCTD nanoemulsion. Hence, a new “easy-to-make” nanoformulation with therapeutic potential on melanoma cells was developed, as a possible adjuvant for future melanoma treatment. MDPI 2023-03-28 /pmc/articles/PMC10143330/ /pubmed/37111258 http://dx.doi.org/10.3390/ph16040501 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Martínez-Razo, Gabriel Pires, Patrícia C. Domínguez-López, María Lilia Veiga, Francisco Vega-López, Armando Paiva-Santos, Ana Cláudia Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells |
title | Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells |
title_full | Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells |
title_fullStr | Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells |
title_full_unstemmed | Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells |
title_short | Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells |
title_sort | norcantharidin nanoemulsion development, characterization, and in vitro antiproliferation effect on b16f1 melanoma cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143330/ https://www.ncbi.nlm.nih.gov/pubmed/37111258 http://dx.doi.org/10.3390/ph16040501 |
work_keys_str_mv | AT martinezrazogabriel norcantharidinnanoemulsiondevelopmentcharacterizationandinvitroantiproliferationeffectonb16f1melanomacells AT pirespatriciac norcantharidinnanoemulsiondevelopmentcharacterizationandinvitroantiproliferationeffectonb16f1melanomacells AT dominguezlopezmarialilia norcantharidinnanoemulsiondevelopmentcharacterizationandinvitroantiproliferationeffectonb16f1melanomacells AT veigafrancisco norcantharidinnanoemulsiondevelopmentcharacterizationandinvitroantiproliferationeffectonb16f1melanomacells AT vegalopezarmando norcantharidinnanoemulsiondevelopmentcharacterizationandinvitroantiproliferationeffectonb16f1melanomacells AT paivasantosanaclaudia norcantharidinnanoemulsiondevelopmentcharacterizationandinvitroantiproliferationeffectonb16f1melanomacells |